Video Testimonials Improve Consensus Regarding Patients' Wishes
Adding a patient-created video testimonial to a living will or "POLST" form makes it easier for medical providers to interpret patients' wishes for critical versus end-of-life care, according to a study published in Journal of Patient Safety. "Our study shows that medical professionals are more likely to reach a consensus after viewing a video testimonial, proving that we can do better than paper forms alone," says lead author Dr. Ferdinando L. Mirarchi of University of Pittsburgh Medical Center (UPMC) Hamot, in Erie, Pa.
See Also: ICU Organisational Changes: Impact on Patient Outcome and Cost
Written documents such as living wills (LWs) seek to direct medical treatments in the event the patient loses decision-making capacity. A newer type of document – called Physician Orders for Life-Sustaining Treatment, or POLST – provides a one-page format for seriously ill patients to indicate their treatment preferences. However, both LWs and POLST are prone to medical errors related to provider misinterpretation of what is documented and appropriate patient selection. Dr. Mirarchi notes three ways in these medical errors can cause harm: by taking a life inappropriately, by preventing the natural dying process, or by leading to overuse of costly medical resources.
In a nationwide internet survey, 741 physicians at 13 hospitals were presented with clinical scenarios involving critically ill patients who had either an LW or POLST. Doctors were randomly assigned to interpret the patients' wishes based on the LW or POLST alone, or with the addition of a scripted video testimonial in which patients talked about their treatment choices.
Responses were compared to see if the video testimonials led to more accurate interpretation of the patient's intentions. Choices included full aggressive treatment including CPR; aggressive care with a brief attempt at CPR; or no CPR/'allow natural death.'
The researchers found that doctors reached a higher level of agreement in interpreting the patients' wishes when they viewed the video testimonials. Based on the LW or POLST documents only, doctors reached a consensus (95 percent agreement) in two out of nine clinical scenarios.
Furthermore, adding the video testimonials produced statistically significant changes in the responses of seven scenarios – in five of these, physicians were more likely to choose full aggressive treatment. Overall, the addition of a video testimonial was the most consistent predictor of resuscitation choices achieving interpretive consensus.
"Video testimonials can ensure the safe interpretation of LWs and POLST documents and ensure that these documents are faithful to the wishes and goals of the patient producing benefits for all stakeholders in the health care system," the study concludes.
Source: Wolters Kluwer Health
Image Credit: Pixabay
Published on : Tue, 21 Feb 2017
A high-end ventilator featured with 1080P HD wide screen, combines an intuitive customized UI with powerful assistive tools and modules. Operate with Ease In the modern busy clinical environment, ease of use is a fundamental requirement for all...
Features SV 300 is a state-of-the-art ventilator that’s simple to configure, easy to operate and versatile in use. It equips with extensive ventilation modes that can treats pediatric and adult patients with all acuity levels at ICUs and Intermediate...
The fully featured ICU ventilator, HAMILTON-MR1, guarantees uncompromised continuous ventilation care from the ICU to the MRI scanner and back. Its reliability and high performance, with advanced lung-protective strategies and patient-adaptive modes,...
Q-NRG is the first Indirect Calorimeter specifically intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing and for healthy subjects. Q-NRG is a unique product, resulting...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...